Search

everythinglearnresearchcommunity

for

Search:↓

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

3D models and organoids improve liposarcoma research and therapy development.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

ERULUS is crucial for root hair growth by controlling calcium levels.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Epiregulin can help hair grow and may be useful for treating hair loss.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

EF and PXE not closely related.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Injecting specific cells into the skin can help improve skin structure and reduce blisters in a genetic skin disorder.

GABEB is a less severe skin condition caused by a gene mutation affecting collagen, leading to blisters and other symptoms.

Correcting EDA fibronectin organization and YAP translocation can improve wound healing in fibrotic conditions.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Scientists used stem cells to create a model of the skin disease Epidermolysis Bullosa simplex, which helped them understand its molecular mechanisms and could aid in finding treatments.